Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
Enregistré dans:
Auteurs principaux: | Dimitrios A. Vrachatis, George V. Giannopoulos, Sotiria G. Giotaki, Konstantinos Raisakis, Charalampos Kossyvakis, Konstantinos E. Iliodromitis, Bernhard Reimers, Dimitrios Tousoulis, Michael Cleman, Christodoulos Stefanadis, Alexandra Lansky, Spyridon G. Deftereos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a869b498aed8479c82486d97d1a2e7cb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
par: Dimitrios A. Vrachatis, et autres
Publié: (2021) -
Association Between Colchicine Treatment and Clinical Outcomes in Patients with Coronary Artery Disease: Systematic Review and Meta-analysis
par: Francesco Condello, et autres
Publié: (2021) -
Cardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber Mechanics
par: Christos-Konstantinos Antoniou, et autres
Publié: (2019) -
Colchicine inhibits ROS generation in response to glycoprotein VI stimulation
par: G. J. Pennings, et autres
Publié: (2021) -
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
par: Kalliopi Klavdianou, et autres
Publié: (2021)